Discontinuation report LYNPARZA

Last updated on 2021-02-25 History
Report ID 134652
Drug Identification Number 02454408
Brand name LYNPARZA
Common or Proper name olaparib
Company Name ASTRAZENECA CANADA INC
Market Status CANCELLED POST MARKET
Active Ingredient(s) OLAPARIB
Strength(s) 50MG
Dosage form(s) CAPSULE
Route of administration ORAL ORAL
Packaging size Bottle of 112 capsules
ATC code L01XX
ATC description OTHER ANTINEOPLASTIC AGENTS
Reason for discontinuation Business reasons
Anticipated discontinuation date 2021-12-01
Actual discontinuation date 2021-01-11
Remaining supply date 2021-01-11
Discontinuation status Discontinued
Discontinuation decision reversal No
Information on remaining supply There are no known supply of this drug available for sale on the market
Company comments
Health Canada comments
Tier 3 Status No
Company contact information Please contact AstraZeneca Canada Medical Information for any specific questions at 1-800-668-6000 (EN) or 1-800-461-3787 (FR) or by email: medinfo.canada@astrazeneca.com.

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v3 2021-02-25 French Compare
v2 2021-02-25 French Compare
v1 2021-02-25 English Compare

Showing 1 to 3 of 3